Serovars and antimicrobial resistance of non-typhoidal Salmonella from human patients in Shanghai, China, 2006-2010

Epidemiology and Infection

Volumn 142, Issue 4, 2014, Pages 826-832

  Zhang, J ^a   Jin, H ^b   Hu, J ^b   Yuan, Z ^b   Shi, W ^c   Ran, L ^d   Zhao, S ^e   Yang, X ^a   Meng, J ^f   Xu, X ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Shanghai Municipal Ke Ma Jia Technology Center for Microbiology   (China)

^d CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^e Center for Veterinary Medicine   (United States)

^f UNIVERSITY OF MARYLAND   (United States)

Author keywords

Antimicrobial resistance; Salmonella; serovars

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAMASE INHIBITOR; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTIOFUR; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; NALIDIXIC ACID; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; SULFAFURAZOLE; SULFONAMIDE; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CHILD; CHINA; DIARRHEA; FECES ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; RETROSPECTIVE STUDY; REVIEW; SALMONELLA ENTERITIDIS; SALMONELLA TYPHIMURIUM; SEROTYPE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; LOOSE FECES; SALMONELLA; SALMONELLA ABERDEEN; SALMONELLA AGONA; SALMONELLA DERBY; SALMONELLA INFANTIS; SALMONELLA LONDON; SALMONELLA MELEAGRIDIS; SALMONELLA SENFTENBERG; SALMONELLA THOMPSON; CHI SQUARE DISTRIBUTION; CLASSIFICATION; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; SALMONELLOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CHINA; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SALMONELLA; SALMONELLA INFECTIONS; YOUNG ADULT;

EID: 84901724247     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813001659     Document Type: Review

References (32)

1. Tauxe RV. Emerging foodborne diseases: an evolving public health challenge. Emerging Infectious Diseases 1997; 3: 425-434.
2. Majowicz SE, et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clinical Infectious Diseases 2010; 50: 882-889.
3. Gomez TM, et al. Foodborne salmonellosis. World Health Statistics Quarterly 1997; 50: 81-89.
4. World Health Organization (WHO). WHO global strategy for containment of antimicrobial resistance. WHO, Switzerland, 2001.
5. Cailhol J, et al. Trends in antimicrobial resistance phenotypes in non-typhoid Salmonella from human and poultry origins in France. Epidemiology and Infection 2006; 134: 171-178.
6. Lauderdale TL, et al. Multidrug resistance among different serotypes of clinical Salmonella isolates in Taiwan. Diagnostic Microbiology Infectious Disease 2006; 55: 149-155.
7. Van Duijkeren E, et al. Antimicrobial susceptibilities of Salmonella strains isolated from humans, cattle, pigs, and chickens in the Netherlands from 1984 to 2001. Journal of Clinical Microbiology 2003; 41: 3574-3578.
8. Xia S, et al. Molecular characterization and antimicrobial susceptibility of Salmonella isolates from infections in humans in Henan Province, China. Journal of Clinical Microbiology 2009; 47: 401-409.
9. Threlfall EJ, et al. Antimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: results of international multi-centre surveillance. Eurosurveillance 2003; 8: 41-45.
10. Centers for Disease Control and Prevention (CDC). Diagnosis and management of foodborne illnesses: a primer for physicians and other health care professionals. Morbidity and Mortality Weekly Report 2004; 53: 1-33.
11. World Health Organization (WHO). Isolation of Salmonella and Shigella from faecal specimens. WHO Global Foodborne Infections Network, 2010 (http://www.who.int/gfn/en/). Accessed 15 December 2011.
12. World Health Organization (WHO). Collaborating Centre for Reference and Research on Salmonella. Antigenic formulae of the Salmonella serovars. Paris: Pasteur Institute, 2001.
13. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests. M02-A10. Villanova, PA, USA: CLSI, 2009.
14. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 20th informational supplement. M100-S20. Villanova, PA, USA: CLSI, 2010.
15. Herikstad H, et al. Salmonella surveillance: a global survey of public health serotyping. Epidemiology and Infection 2002; 129: 1-8.
16. Galanis E, et al. Web-based surveillance and global Salmonella distribution, 2000-2002. Emerging Infectious Diseases 2006; 12: 381-388.
17. Liebana E, et al. Molecular typing of Salmonella serotypes prevalent in animals in England: assessment of methodology. Journal of Clinical Microbiology 2001; 39: 3609-3616.
18. Martinez-Urtaza J, et al. Detection of Salmonella Senftenberg associated with high saline environments in mussel processing facilities. Journal of Food Protection 2004; 67: 256-263.
19. Cui S, et al. Ciprofloxacin-resistant Salmonella enterica serotype Typhimurium, China. Emerging Infectious Diseases 2008; 14: 493-5.
20. Ashtiani MT, et al. Trends in antimicrobial resistance of fecal Shigella and Salmonella isolates in Tehran, Iran. Indian Journal of Pathology and Microbiology 2009; 52: 52-55.
21. Travers K, Barza M. Morbidity of infections caused by antimicrobial-resistant bacteria. Clinical Infectious Diseases 2002; 34: S131-S134.
22. Breuil J, et al. Antibiotic resistance in Salmonellae isolated from humans and animals in France: comparative data from 1994 and 1997. Journal of Antimicrobial Chemotherapy 2000; 46: 965-971.
23. Prats G, et al. Antibiotic resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona. Antimicrobial Agents and Chemotherapy 2000; 44: 1140-1145.
24. Threlfall EJ, et al. Resistance to ciprofloxacin in nontyphoidal Salmonellas from humans in England and Wales-the current situation. Clinical Microbiology and Infection 1999; 5: 130-134.
25. Singh S, et al. Antibiotic resistance pattern among the Salmonella isolated from human, animal and meat in India. Tropical Animal Health and Production 2012; 44: 665-674.
26. Torpdahl M, et al. Human isolates of Salmonella enterica serovar Typhimurium from Taiwan displayed significantly higher levels of antimicrobial resistance than those from Denmark. International Journal of Food Microbiology 2013; 161: 69-75.
27. Centers for Disease Control and Prevention (CDC). National Antimicrobial Resistance Monitoring System for Enteric Bacteria. (NARMS): Human isolates, final report, 2010 (http://www.cdc.gov/narms/pdf/2010-annualreport- narms.pdf), 2010.
28. Yoo S, et al. Epidemiology of Salmonella enterica serotype typhi infections in Korea for recent 9 years: trends of antimicrobial resistance. Journal of Korean Medical Science 2004; 19: 15-20.
29. Deng X, et al. Laboratory-based surveillance of non-typhoidal Salmonella infections in Guangdong Province, China. Foodborne Pathogens and Disease 2012; 9: 305-312.
30. Ran L, et al. Laboratory-based surveillance of nontyphoidal Salmonella infections in China. Foodborne Pathogens and Disease 2011; 8: 921-927.
31. Shahada F, et al. Antimicrobial susceptibility phenotypes, resistance determinants and DNA fingerprints of Salmonella enterica serotype Typhimurium isolated from bovine in Southern Japan. International Journal of Antimicrobial Agents 2007; 30: 150-156.
32. Paterson DL, Bonomo RA. Extended-spectrum betalactamases: a clinical update. Clinical Microbiology Reviews 2005; 18: 657-686.